Faron's Financial Statement Release January 1 to December :

TURKU, Finland and BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- Faron Pharmaceuticals Ltd. (

Related Keywords

Boston , Massachusetts , United States , Seattle , Washington , Finland , Jukka , Lapland , Fred Hutchinson Cancer Research Center , American , Finnish , Frank Armstrong , Birge Berns , Juha Karttunen , Lindsey Neville , Gregoryb Brown , Jo Turner , David Daley , James Obrien , Anne Whitaker , Leopoldo Zambeletti , Christine Roth , Markku Jalkanen , Christopher Golden , Mary Jane Elliott , Sandy Jamieson , Johnson , European Hematology Association Congress , Faron Pharmaceuticals Ltd , Sanofi Aventis , European Hematology Association , American Association For Cancer Research Annual Meeting , Faron Pharmaceuticals Oy , Seagen Inc , American Society Of Hematology , Faron Pharmaceuticals Ltd As Borrower Facilities Agreement , Peel Hunt , Directors Of The Company , International Accounting Standard , Drug Administration , Cairn Financial Advisers , Finnish Companies , First North , Orphan Drug Designation , Cell Reports , Chief Executive Officer , American Society , Annual Meeting , American Association , Cancer Research Annual Meeting , Chief Financial , Non Executive Directors , Chief Medical Officer , Executive Vice President , Non Executive Director , Chief Medical , Facilities Agreement , Director Proposal , Annual General Meeting , Jameso Brien , Chief Financial Officer , Jane Elliott , Certified Adviser , Nasdaq First , Cell Reports Medicine , Faron Board Member , Interim Chief Medical , Financial Statements , Capital Loan , Finnish Companies Act , Investment Round , Due Date , Final Due Date , Extraordinary General Meeting , Income Statement , Balance Sheet , Cash Flow Statement ,